Skip to main content
. 2022 Apr 26;3(2):45–50. doi: 10.14744/hf.2022.2022.0004

Table 1.

Characteristics of the participants according to the presence of NAFLD with normal and elevated transaminases

  Normal enzyme level (n=26) High enzyme level (n=26) p
Age (years) 44.69±6.02 46.38±8.31 0.405
Cholesterol (mg/dL) 217.65±41.70 224.85±51.26 0.581
Triglyceride (mg/dL) 185.11±105.33 181.92±98.54 0.911
AST/ALT 0.87±0.21 0.68±0.14 0.001
ALP (IU/L) 205.04±57.10 220.73±91.76 0.463
GGT (U/L) 40.73±29.15 58.23±33.70 0.050
Total bilirubin (mg/dL) 0.49±0.21 0.77±0.39 0.002
Direct bilirubin (mg/dL) 0.11±0.04 0.16±0.10 0.033
Albumin/globulin 1.36±0.15 1.38±0.15 0.765
Iron (µg/dL) 77.19±29.67 103.00±39.27 0.010
Ferritin (mL/ng) 58.47±77.98 133.77±114.92 0.001
C-reactive protein (mg/L) 7.08±5.96 8.20±10.33 0.978
HbA1c (%) 6.01±1.14 5.97±1.10 0.894
HA level 24.91±12.59 41.30±52.10 0.272
Gender     0.099
 Male 1 (4) 6 (23)  
 Female 25 (96) 20 (77)  
Diabetes     0.588
 Normal 13 (50) 14 (54)  
 Prediabetes 5 (19) 7 (27)  
 Diabetes 8 (31) 55 (19)  
Steatosis degree     0.007
 1 17 (65) 10 (38)  
 2 9 (35) 8 (31)  
 3 0 (0) 8 (31)  
Steatohepatitis degree     0.390
 0 1 (4) 1 (4)  
 1 21 (81) 16 (61)  
 2 4 (15) 8 (31)  
 3 0 (0) 1 (4)  
Fibrosis stage     0.308
 0 23 (89) 20 (77)
 1 3 (11) 4 (15)  
 2 0 (0) 2 (8)  
CT stage     0.002
 0 7 (32) 0 (0)  
 1 9 (41) 3 (17)  
 2 6 (27) 11 (61)  
 3 0 (0) 4 (22)  
Cholesterol level     0.687
 Normal 14 (54) 11 (42)  
 25% less than normal 10 (39) 13 (50)  
 25% more than normal 2 (7) 2 (8)  
Triglyceride level     0.849
 Normal 15 (58) 17 (65)  
 25% less than normal 6 (23) 5 (19)  
 25% more than normal 5 (19) 4 (15)  

AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; GGT: Gamma-glutamyl transferase; HA: Hyaluronic acid; CT: Computed tomography; HbA1c: Hemoglobin A1c. Continuous variables are expressed as mean±standard deviation, and categorical variables are expressed as numbers and percentages.